4//SEC Filing
MCCORMICK FRANK 4
Accession 0001470831-25-000278
CIK 0001743881other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:10 PM ET
Size
5.5 KB
Accession
0001470831-25-000278
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Sale
Common Stock
2025-10-27$65.00/sh−1,641$106,665→ 878,338 total(indirect: By Trust)
Holdings
- 83,275
Common Stock
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001257809
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 5:10 PM ET
- Size
- 5.5 KB